Literature DB >> 25451672

Intensity-modulated whole pelvic radiotherapy provides effective dosimetric outcomes for cervical cancer treatment with lower toxicities.

Y Lv1, F Wang1, L Yang1, G Sun2.   

Abstract

PURPOSE: To compare the efficacy of intensity-modulated radiotherapy, three-dimensional conformal radiotherapy, and conventional radiotherapy for cervical cancer treatment.
MATERIALS AND METHODS: Whole pelvis intensity-modulated radiotherapy, three-dimensional conformal radiotherapy, and conventional radiotherapy plans were designed for 16 patients with stage IIB cervical cancer, each using the prescribed dose of 50.4 Gy/28 fractions. Dose-volume histograms of the target volume and organs at risk were evaluated.
RESULTS: Compared to the 3D conformal and conventional radiotherapy plans, the intensity-modulated radiotherapy plan demonstrated superior conformal treatment. The mean planning target volume dose of all three plans reached the target effective therapeutic dose. The planning target volume dose of the intensity-modulated radiotherapy plan was significantly higher than that of either the three-dimensional conformal radiotherapy or conventional radiotherapy plan (P<0.05). When more than 30 Gy was administered in intensity-modulated radiotherapy, organs at risk including the small intestine, rectum, bladder, and bone marrow received a significantly reduced volume of radiation. In comparison of the average planning target volume doses, significant volume reductions in irradiation of organs at risk were obtained with full bladders.
CONCLUSIONS: An intensity-modulated radiotherapy plan with appropriate margins encompassing the primary tumour and potential microscopic pelvic disease reduces the dose to organs at risk without compromising target coverage. Intensity-modulated radiotherapy is an appropriate definitive treatment for patients with cervical cancer.
Copyright © 2014. Published by Elsevier SAS.

Entities:  

Keywords:  Bladder filling; Cancer du col utérin; Cervical cancer; Intensity-modulated radiotherapy (IMRT); Radiothérapie conformationnelle avec modulation d’intensité; Remplissage vésical

Mesh:

Year:  2014        PMID: 25451672     DOI: 10.1016/j.canrad.2014.08.005

Source DB:  PubMed          Journal:  Cancer Radiother        ISSN: 1278-3218            Impact factor:   1.018


  5 in total

1.  Dosimetric influence of photon beam energy and number of arcs on volumetric modulated arc therapy in carcinoma cervix: A planning study.

Authors:  Girigesh Yadav; Manindra Bhushan; Abhinav Dewan; Upasna Saxena; Lalit Kumar; Deepika Chauhan; Kothanda Raman; Swarupa Mitra; Mahammood Suhail
Journal:  Rep Pract Oncol Radiother       Date:  2016-10-17

2.  Cervical cancer treated with reduced-volume intensity-modulated radiation therapy base on Sedlis criteria (NCCN VS RTOG).

Authors:  Hua-Chun Luo; Gui-Shan Lin; Shao-Guang Liao; Feng-Mei Wang; Hui-Hua Cheng; Jing Feng; Qin Yin; Qun-Hua Chen; Jin-Feng Zhu; Jian-Feng Xu; Dian Wang; Zhi-Chao Fu
Journal:  Br J Radiol       Date:  2017-12-05       Impact factor: 3.039

3.  IMRT and brachytherapy comparison in gynaecological cancer treatment: thinking over dosimetry and radiobiology.

Authors:  Valentina Pinzi; Valeria Landoni; Federica Cattani; Roberta Lazzari; Barbara Alicja Jereczek-Fossa; Roberto Orecchia
Journal:  Ecancermedicalscience       Date:  2019-12-17

4.  Radical radiotherapy in patients with cervix uteri carcinoma: experience of Ondokuz Mayis University.

Authors:  Alparslan Serarslan; Bilge Gursel; Deniz Meydan; Nilgun Ozbek Okumus
Journal:  BMC Cancer       Date:  2019-12-12       Impact factor: 4.430

5.  High precision radiotherapy including intensity-modulated radiation therapy and pulsed-dose-rate brachytherapy for cervical cancer: a retrospective monoinstitutional study.

Authors:  Andrea Vavassori; Giulia Riva; Ruggero Spoto; Roberta Lazzari; Cristiana Fodor; Samantha Dicuonzo; Claudia Maria Francia; Matteo Augugliaro; Giuseppe Facondo; Raffaella Cambria; Stefania Comi; Federica Cattani; Francesca Botta; Vincenzo Bagnardi; Stefania Rizzo; Nicoletta Colombo; Roberto Orecchia; Barbara Alicja Jereczek-Fossa
Journal:  J Contemp Brachytherapy       Date:  2019-12-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.